A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment
Brain Communications · 2025-09-01 · 7 (5)
DOI: 10.1093/braincomms/fcaf279 ↗At a glance
Journal article in Brain Communications, published online on 2025-09-01. Written by George Stothart and 4 co-authors. Institution: Department of Psychology, University of Bath, Bath BA2 7AY, England, UK. Cited 7 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0). Funded by: The Academy of Medical Sciences.
Abstract (original language)
As viable pharmacotherapies and blood biomarkers emerge for dementia treatment and screening, there remains a great need for accurate, sensitive biomarkers of cognitive function. We have previously demonstrated that Fastball, a new Electroencephalography (EEG) method for the passive and objective measurement of recognition memory that requires no behavioural memory response or task comprehension, is sensitive to cognitive dysfunction in Alzheimer's disease. Here we present new evidence that Fastball is sensitive to amnestic dysfunction in an earlier stage of the dementia lifecourse, Mild Cognitive Impairment (MCI). 53 MCI patients and 54 healthy older adult (HOA) controls completed a 3-min Fastball task in which they passively viewed rapidly presented images while EEG captured their automatic ability to differentiate between images based on previous exposure. They also completed neuropsychological assessments of memory (Delayed Match to Sample-48), sustained attention (Psychomotor Vigilance Task), and general cognitive function (Addenbrookes Cognitive Exam-iii). Participants were re-tested after 1 year to establish the test-retest reliability of Fastball in HOAs, and the sensitivity of Fastball to cognitive decline in MCI patients, over a 1 year period. Amnestic MCI patients showed significantly reduced Fastball responses compared with non-amnestic MCI patients (P = 0.001, Cohen's d = 0.98) and HOA controls (P = 0.005, Cohen's d = 0.64). Regression analyses showed that Fastball EEG responses were selectively predictive of neuropsychological measures of recognition memory and not attention. Between baseline and year one follow-up Fastball showed moderate to good test-retest reliability in HOA controls, and the six MCI-dementia converters showed a trend for lower Fastball responses at baseline which will be confirmed with further longitudinal assessment. Fastball is further validated as a viable method for testing recognition memory in cognitively impaired populations. We have demonstrated that it is selectively predictive of memory dysfunction and not attention or other cognitive functions. It is passive, non-invasive, quick to administer and uses cheap, scalable EEG technology. Fastball is a viable functional biomarker that can help to advance cognitive assessment in MCI.
Subjects
Author keywords
Authors and institutions
- Department of Psychology, University of Bath, Bath BA2 7AY, England, UK.
- Bristol Medical School, University of Bristol, Bristol BS8 1QU, England, UK.
ORCID profiles: George Stothart, Sam Creavin, Elizabeth J Coulthard
Funding
- The Academy of Medical Sciences
Cite
APA
Stothart, G., Alderman, S., Hermann, O., Creavin, S., & Coulthard, E. J. (2025). A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment. Brain Communications, 7(5). https://doi.org/10.1093/braincomms/fcaf279
Vancouver
Stothart G, Alderman S, Hermann O, Creavin S, Coulthard EJ. A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment. Brain Communications. 2025;7(5). doi:10.1093/braincomms/fcaf279
BibTeX
@article{Stothart2025,
author = {Stothart, George and Alderman, Sophie and Hermann, Oliver and Creavin, Sam and Coulthard, Elizabeth J},
title = {A passive and objective measure of recognition memory in mild cognitive impairment using Fastball memory assessment},
journal = {Brain Communications},
year = {2025},
volume = {7},
number = {5},
doi = {10.1093/braincomms/fcaf279}
}
EUVIMED